QQQ   423.48 (-0.90%)
AAPL   181.41 (-0.08%)
MSFT   399.17 (-0.90%)
META   467.57 (-0.78%)
GOOGL   142.18 (+0.75%)
AMZN   167.58 (+0.30%)
TSLA   192.30 (-0.75%)
NVDA   671.04 (-3.38%)
NIO   6.02 (+1.01%)
AMD   163.32 (-1.43%)
BABA   75.63 (+3.40%)
T   16.97 (+0.35%)
F   12.08 (-1.39%)
MU   80.59 (-0.15%)
CGC   3.39 (-4.24%)
GE   148.22 (-0.27%)
DIS   107.71 (-1.58%)
AMC   4.57 (-1.93%)
PFE   27.47 (-0.43%)
PYPL   57.61 (-1.74%)
XOM   104.37 (+1.58%)
QQQ   423.48 (-0.90%)
AAPL   181.41 (-0.08%)
MSFT   399.17 (-0.90%)
META   467.57 (-0.78%)
GOOGL   142.18 (+0.75%)
AMZN   167.58 (+0.30%)
TSLA   192.30 (-0.75%)
NVDA   671.04 (-3.38%)
NIO   6.02 (+1.01%)
AMD   163.32 (-1.43%)
BABA   75.63 (+3.40%)
T   16.97 (+0.35%)
F   12.08 (-1.39%)
MU   80.59 (-0.15%)
CGC   3.39 (-4.24%)
GE   148.22 (-0.27%)
DIS   107.71 (-1.58%)
AMC   4.57 (-1.93%)
PFE   27.47 (-0.43%)
PYPL   57.61 (-1.74%)
XOM   104.37 (+1.58%)
QQQ   423.48 (-0.90%)
AAPL   181.41 (-0.08%)
MSFT   399.17 (-0.90%)
META   467.57 (-0.78%)
GOOGL   142.18 (+0.75%)
AMZN   167.58 (+0.30%)
TSLA   192.30 (-0.75%)
NVDA   671.04 (-3.38%)
NIO   6.02 (+1.01%)
AMD   163.32 (-1.43%)
BABA   75.63 (+3.40%)
T   16.97 (+0.35%)
F   12.08 (-1.39%)
MU   80.59 (-0.15%)
CGC   3.39 (-4.24%)
GE   148.22 (-0.27%)
DIS   107.71 (-1.58%)
AMC   4.57 (-1.93%)
PFE   27.47 (-0.43%)
PYPL   57.61 (-1.74%)
XOM   104.37 (+1.58%)
QQQ   423.48 (-0.90%)
AAPL   181.41 (-0.08%)
MSFT   399.17 (-0.90%)
META   467.57 (-0.78%)
GOOGL   142.18 (+0.75%)
AMZN   167.58 (+0.30%)
TSLA   192.30 (-0.75%)
NVDA   671.04 (-3.38%)
NIO   6.02 (+1.01%)
AMD   163.32 (-1.43%)
BABA   75.63 (+3.40%)
T   16.97 (+0.35%)
F   12.08 (-1.39%)
MU   80.59 (-0.15%)
CGC   3.39 (-4.24%)
GE   148.22 (-0.27%)
DIS   107.71 (-1.58%)
AMC   4.57 (-1.93%)
PFE   27.47 (-0.43%)
PYPL   57.61 (-1.74%)
XOM   104.37 (+1.58%)
NASDAQ:ABCM

Abcam (ABCM) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$23.99
$23.99
50-Day Range
$23.07
$23.99
52-Week Range
$12.48
$25.32
Volume
3,300 shs
Average Volume
3.08 million shs
Market Capitalization
$5.50 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.00

Abcam MarketRank™ Stock Analysis

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
4.1% Downside
$23.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
29.55%
From $0.44 to $0.57 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.22 out of 5 stars

Medical Sector

1811th out of 1,856 stocks

Biotechnology Industry

23rd out of 26 stocks


ABCM stock logo

About Abcam Stock (NASDAQ:ABCM)

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.


ABCM Stock News Headlines

Headwaters Capital Q4 2023 Investor Letter
Abcam plc (ABCM) Interactive Stock Chart - Yahoo Finance
An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
Abcam-Danaher Deal Receives All Identified Clearances - Quick Facts
An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
Jonathan Milner Issues Statement Responding to ISS Report
Abcam (ABCM) Gets a Hold from RBC Capital
ABCAM INVESTOR ALERT by the Former Attorney...
Bank of America Securities Remains a Buy on Abcam (ABCM)
See More Headlines
Receive ABCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
2/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:ABCM
Fax
N/A
Employees
1,760
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.00
High Stock Price Target
$23.00
Low Stock Price Target
$23.00
Potential Upside/Downside
-4.1%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$379.70 million
Cash Flow
$0.60 per share
Book Value
$3.92 per share

Miscellaneous

Free Float
213,842,000
Market Cap
$5.50 billion
Optionable
Not Optionable
Beta
0.86
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Alan Thomas Hirzel BS (Age 55)
    M.B.A., M.S., CEO & Executive Director
    Comp: $1.18M
  • Mr. Michael Shaun Baldock B.A. (Age 59)
    CFO & Director
    Comp: $876.48k
  • Marc Leigh Russell Perkins
    General Counsel & Company Secretary
  • Emma Sceats
    Senior Vice President of Sales & Marketing
  • Mr. Nick Skinner
    Senior Vice President of Human Resources
  • Ms. Alejandra Solache Ph.D.
    Senior Vice President of Research & Development
  • Mr. John Baker
    Senior Vice President of Supply Chain & Manufacturing
  • Juan Carlos Sacristan
    Senior Vice President of Data & Digital














ABCM Stock Analysis - Frequently Asked Questions

Should I buy or sell Abcam stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last year. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ABCM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABCM, but not buy additional shares or sell existing shares.
View ABCM analyst ratings
or view top-rated stocks.

What is Abcam's stock price target for 2024?

5 Wall Street research analysts have issued twelve-month price targets for Abcam's shares. Their ABCM share price targets range from $23.00 to $23.00. On average, they predict the company's share price to reach $23.00 in the next twelve months. This suggests that the stock has a possible downside of 4.1%.
View analysts price targets for ABCM
or view top-rated stocks among Wall Street analysts.

What ETFs hold Abcam's stock?
When did Abcam IPO?

(ABCM) raised $149 million in an IPO on Thursday, October 22nd 2020. The company issued 9,000,000 shares at a price of $16.52 per share. Morgan Stanley, BofA Securities, SVB Leerink, Lazard and William Blair served as the underwriters for the IPO.

Who are Abcam's major shareholders?

Abcam's stock is owned by many different institutional and retail investors. Top institutional investors include Bluefin Capital Management LLC (0.00%), HAP Trading LLC (0.00%), Citadel Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%).

This page (NASDAQ:ABCM) was last updated on 2/21/2024 by MarketBeat.com Staff